Literature DB >> 35341139

Erratum to "Qing-Kai-Ling Injection Acts Better Than Shen-Fu Injection in Enhancing the Antitumor Effect of Gefitinib in Resistant Non-Small Cell Lung Cancer Models".

Ya-Ya Yu1,2, Yan-Juan Zhu1,2,3,4, Ying Zou1,5, Zhen-Zhen Xiao1,2, Shuai Shi1,6, Yi-Hong Liu1,2, Xue-Song Chang1,2, Ya-Dong Chen1,2, Hai-Bo Zhang1,2,3,4,7.   

Abstract

[This corrects the article DOI: 10.1155/2021/9911935.].
Copyright © 2022 Ya-Ya Yu et al.

Entities:  

Year:  2022        PMID: 35341139      PMCID: PMC8956390          DOI: 10.1155/2022/9808974

Source DB:  PubMed          Journal:  Evid Based Complement Alternat Med        ISSN: 1741-427X            Impact factor:   2.629


In the article titled “Qing-Kai-Ling Injection Acts Better Than Shen-Fu Injection in Enhancing the Antitumor Effect of Gefitinib in Resistant Non-Small Cell Lung Cancer Models” [1], the author's contributions statement was missing. The correct Authors' Contributions section is as follows: Ya-Ya Yu and Yan-Juan Zhu contributed equally to this work. Ya-ya Yu and Zhen-zhen Xiao performed the biological experiments in vitro. Ying Zou and Shuai Shi performed the biological experiments in vivo. Yi-hong Liu, Xue-song Chang, and Ya-dong Chen did the statistical analysis. Hai-bo Zhang conceived and supervised the study. Yan-juan Zhu and Ya-ya Yu drafted the manuscript. All the authors read and approved the final manuscript. The error was introduced during the production process of the article, and Hindawi apologises for causing this error in the article.
  1 in total

1.  Qing-Kai-Ling Injection Acts Better Than Shen-Fu Injection in Enhancing the Antitumor Effect of Gefitinib in Resistant Non-Small Cell Lung Cancer Models.

Authors:  Ya-Ya Yu; Yan-Juan Zhu; Ying Zou; Zhen-Zhen Xiao; Shuai Shi; Yi-Hong Liu; Xue-Song Chang; Ya-Dong Chen; Hai-Bo Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-04       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.